Robot vs. laparoscope: which surgery is safer for early stomach cancer?

NCT ID NCT07467174

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two types of minimally invasive surgery for early-stage stomach cancer: a newer robotic method using fewer incisions (reduced-port) and the standard laparoscopic method. About 538 patients will be randomly assigned to one of the two surgeries. The main goal is to see if the robotic approach is as safe as the standard one, looking at complications within 30 days after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
surgery (reduced-port robotic subtotal gastrectomy vs. conventional laparoscopic subtotal gastrectomy)
What this could lead to
If successful, this could show that a less invasive robotic surgery is as safe as standard laparoscopic surgery for early gastric cancer, potentially leading to faster recovery and less pain.
What could go wrong
This is an early-stage comparison trial, not a test of a new drug or cure. The results may not apply to all patients or cancer stages, and the robotic approach may not prove superior.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EARLY GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Gastrointestinal Surgery, Department of Surgery Severance Hospital, Yonsei University College of Medicine

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.